Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|November 26, 2008
Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitorsMario Sechi, Giuseppe Rizzi, Alessia Bacchi, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 9, 2014
Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitorsAndrea Trabocchi, Nicolino Pala, Ilga Krimmelbein, et al.RSC Medicinal Chemistry|March 4, 2026
Harnessing oligonucleotide architecture for potent multivalent inhibition of human carbonic anhydrasesEslam M Abbass, Federico Ladu, Justine Mansot, et al.Scientific Reports|October 26, 2018
Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma modelsMario Sechi, Rahul K Lall, Saheed O Afolabi, et al.Molecular Pharmaceutics|February 18, 2011
HIV-1 IN strand transfer chelating inhibitors: a focus on metal bindingAlessia Bacchi, Mauro Carcelli, Carlotta Compari, et al.European Journal of Medicinal Chemistry|July 5, 2014
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitorsMauro Carcelli, Dominga Rogolino, Mario Sechi, et al.Nanoscale Research Letters|June 30, 2011
Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studiesVanna Sanna, Anna Maria Roggio, Anna Maria Posadino, et al.RNA Nanomed|October 17, 2025
RNA Nanoparticles Harboring Radioisotopes or Other Imaging Molecules for Spontaneous Tumor Targeting for Early Cancer DiagnosisDaniel W Binzel, Congcong Xu, Katherine Binzel, et al.Journal of Medicinal Chemistry|February 11, 2011
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cellsVanna Sanna, Gianfranco Pintus, Anna Maria Roggio, et al.Scientific Reports|February 2, 2017
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapyVanna Sanna, Chandra K Singh, Rahime Jashari, et al.Pageof 8